South Korea vs Norway: Prevalence of anemia among women of reproductive age
South Korea
15.7%
in 2023
Norway
16.3%
in 2023
South Korea rank
167th
Norway rank
164th
Prevalence of anemia among women of reproductive age over time
- South Korea
- Norway
How they compare
Norway currently reports 16.3% against 15.7% in South Korea, a difference of 0.6%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was South Korea ahead.
South Korea ranks 167th and Norway ranks 164th of 192 countries.
Across the 3 decades both report, South Korea averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | South Korea | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.3% | 12.4% | 3.9% | South Korea |
| 2010s | 13.6% | 13.2% | 0.4% | South Korea |
| 2020s | 14.9% | 15.5% | 0.5% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, South Korea or Norway?
- Norway, at 16.3% against 15.7% in South Korea as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between South Korea and Norway?
- 0.6%, with Norway ahead.
- How many years of comparable data are there for South Korea and Norway?
- 24 years are reported by both, from 2000 to 2023.
- How do South Korea and Norway rank globally for prevalence of anemia among women of reproductive age?
- South Korea ranks 167th and Norway ranks 164th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.